ReNeuron Presents Positive Data at the 27th Annual Congress of the European Society of Gene and Cell Therapy on Lead Cell Line

Author's Avatar
Oct 24, 2019
Article's Main Image

New data show ReNeuron's lead CTX cell therapy candidate can be re-programmed into a pluripotent state and differentiated into other cell types

These new cell types can be efficiently expanded as potential cell therapy candidates targeting a broad range of diseases

PR Newswire